Search for a command to run...
No recent news available for this stock.
Conference call summary is not available for this stock.
Eiko Lifesciences Ltd. is currently underperforming significantly compared to its peers in the chemicals sector, exhibiting negative growth metrics, high debt levels, and poor profitability ratios. In contrast, peers like Pidilite Industries and Solar Industries are leading in growth and profitability, making them more attractive investments.
Highest ROE (22.45%) and positive revenue growth (6.12% YoY).
Strong profitability metrics with a 29.59% ROE despite recent revenue decline.